Axicabtagene ciloleucelNeurotoxicity: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1892卷 / 1期

关键词：

D O I：

10.1007/s40278-022-09593-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：51 / 51

相关论文

共 50 条

[31] Axicabtagene-ciloleucel/tocilizumabCytokine release syndrome and lack of efficacy: case report
Reactions Weekly, 2022, 1933 (1) : 93 - 93
[32] Axicabtagene ciloleucelPancytopenia; progressive central neurotoxicity in the form of autoimmune encephalitis: case report
Reactions Weekly, 2022, 1916 (1) : 77 - 77
[33] Axicabtagene ciloleucel/tisagenlecleucelLack of efficacy and cytokine-release-syndrome: case report
Reactions Weekly, 2023, 1945 (1) : 109 - 109
[34] Antipsychotics/axicabtagene-ciloleucel/bupropionCytokine release syndrome, neurotoxicity and neutropenia: case report
Reactions Weekly, 2021, 1847 (1) : 71 - 71
[35] Axicabtagene ciloleucelCytokine release syndrome and immune cell associated neurotoxicity syndrome: case report
Reactions Weekly, 2021, 1879 (1) : 61 - 61
[36] Axicabtagene ciloleucelNeutropenic fever and immune effector cell–associated neurotoxicity syndrome: case report
Reactions Weekly, 2021, 1840 (1) : 74 - 74
[37] Axicabtagene ciloleucelInfections: 9 case reports
Reactions Weekly, 2022, 1934 (1) : 93 - 93
[38] Axicabtagene ciloleucelInfections: 9 case reports
Reactions Weekly, 2022, 1923 (1) : 81 - 81
[39] Axicabtagene-ciloleucel/dexamethasoneCytokine release syndrome, myelodysplastic syndrome and lack of efficacy: case report
Reactions Weekly, 2023, 1976 (1) : 65 - 65
[40] Pembrolizumab-induced Remission After Failure of Axicabtagene Ciloleucel: Case Report and Literature Review
Dimou, Maria
Bitsani, Aikaterini
Bethge, Wolfgang
Panayiotidis, Panayiotis
Vassilakopoulos, Theodoros P.
IN VIVO, 2021, 35 (06): : 3401 - 3406

← 1 2 3 4 5 →